In a sweeping global analysis spanning over three decades, researchers have reaffirmed that heart disease and stroke remain the world’s leading causes of death, even as mortality rates from these conditions show a steady decline. The findings come from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2023, which analyzed data from 204 countries and territories, offering one of the most comprehensive views yet of global mortality trends.

Global Mortality Shifts — COVID-19’s Rise and Fall

The study revealed that the COVID-19 pandemic had briefly disrupted long-standing mortality trends, emerging as the leading global cause of death in 2021. But by 2023, the virus had dropped to the 20th position, marking a return to the pre-pandemic dominance of non-communicable diseases such as heart disease and stroke.

Despite their continued lead, both heart disease and stroke have shown notable reductions in age-standardized mortality rates, thanks to improved healthcare, early diagnosis, and preventive measures. “These are encouraging signs that global efforts to tackle cardiovascular disease are paying off,” noted researchers involved in the study.

Progress and Persistent Challenges

The report highlighted major progress in reducing deaths from several infectious diseases. Diarrhoeal diseases, tuberculosis, stomach cancer, and measles have all recorded sharp declines in global mortality rates, underscoring the success of vaccination campaigns, better sanitation, and health system strengthening.

However, the gains are uneven. Regions with fragile healthcare systems continue to bear a disproportionate burden of preventable deaths, especially from neonatal disorders and maternal causes. Despite large reductions in neonatal mortality, such disorders remain the leading cause of years of life lost (YLLs) globally — except in 2021, when COVID-19 briefly overtook it.

A Tale of Two Worlds: High-Income vs Low-Income

The GBD 2023 findings underscore the stark global health divide. In high-income regions, the average age of death in 2023 was 80.9 years for women and 74.8 years for men. By contrast, in sub-Saharan Africa, it remained alarmingly low at just 38 years for women and 35.6 years for men.

“These numbers tell two different stories,” researchers explained. “While some countries are successfully managing chronic diseases of ageing, others are still struggling to control infectious diseases and ensure basic healthcare access.”

Emerging Threats: Drug Use, Diabetes, and Conflict

The study also identified rising threats that could shape the next era of global health. Drug use disorders and diabetes are increasingly contributing to premature deaths, particularly among men. For women, conflict and terrorism were highlighted as growing causes of mortality in certain regions.

Although the overall probability of dying before age 70 has decreased since 2000, the decline has not been uniform. Some low- and middle-income countries are now facing a surge in non-communicable diseases (NCDs) — a shift that marks a new phase in the global health transition.

Living Longer — But Unequally

One of the most hopeful findings is the rise in the global mean age of death, which increased from 46.8 years in 1990 to 63.4 years in 2023. For men, it rose from 45.4 to 61.2 years, and for women, from 48.5 to 65.9 years.

While the world is undoubtedly living longer, the benefits are not shared equally. High-income nations continue to outpace others in life expectancy and healthcare access, highlighting the urgent need for targeted interventions in low-resource settings.

A Call for Resilient Health Systems

The researchers behind the GBD 2023 analysis emphasized that the findings are not just about numbers — they are a call to action. The COVID-19 pandemic, they said, exposed vulnerabilities even in advanced health systems, reinforcing the need for global preparedness and investment in both communicable and non-communicable disease control.

“There’s an ever-growing need for health systems that can withstand future pandemics while addressing the chronic disease burden,” the report concluded. “Our data provide a roadmap for where the world must act to reduce preventable deaths and achieve true health equity.”

The Bottom Line

The GBD 2023 study captures the evolving story of global mortality: one where progress coexists with disparity, and where the world’s biggest killers — heart disease and stroke — remain at the forefront, even as humanity learns to live longer.

As COVID-19’s shadow fades, the message is clear — the fight against heart and stroke disease must remain a global priority, and the goal of equitable, resilient healthcare is more urgent than ever.